AMGEN INC (AMGN) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-06 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: AMGEN INC (AMGN) CIK: 0000318154 --- Reporting Owner --- Name: Miller Derek CIK: 0001917312 Role: Officer (SVP, Human Resources) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-06 | Code: M (Exercise of derivative) Shares: +2,069 | Price: $162.60 Total Value: $336,419.40 Shares Owned After: 14,531 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-08-06 | Code: S (Open market sale) Shares: -2,069 | Price: $402.54 Total Value: $832,864.36 Shares Owned After: 12,462 | Ownership: D (Direct) Footnotes: [F1] Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options. [F2] The price reported is an average price of $402.5444 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer. [Transaction #3] Security: Common Stock Date: 2026-08-06 | Code: M (Exercise of derivative) Shares: +1,821 | Price: $177.46 Total Value: $323,154.66 Shares Owned After: 14,283 | Ownership: D (Direct) [Transaction #4] Security: Common Stock Date: 2026-08-06 | Code: S (Open market sale) Shares: -1,821 | Price: $402.54 Total Value: $733,033.35 Shares Owned After: 12,462 | Ownership: D (Direct) Footnotes: [F1] Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options. [F2] The price reported is an average price of $402.5444 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer. [F3] These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. --- Derivative Transactions --- [Transaction #1] Security: Nqso (Right to Buy) Date: 2026-08-06 | Code: M (Exercise of derivative) Shares: -2,069 | Price: $0.00 Exercisable: N/A | Expires: 2027-05-02 Shares Owned After: 0 | Ownership: D (Direct) [Transaction #2] Security: Nqso (Right to Buy) Date: 2026-08-06 | Code: M (Exercise of derivative) Shares: -1,821 | Price: $0.00 Exercisable: N/A | Expires: 2028-04-27 Shares Owned After: 0 | Ownership: D (Direct) --- Footnotes (Complete Index) --- F1: Includes shares sold to cover the option exercise price and required withholding taxes in connection with the exercise of expiring options. F2: The price reported is an average price of $402.5444 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer. F3: These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. --- Signature --- /s/ /s/ Derek Miller (2026-08-06)